Synopsis of recent research by authors named "Meiying Zhang"
- Meiying Zhang's research primarily focuses on the role of epigenetics in cancer, examining how DNA methylation and gene silencing can influence treatment resistance and progression in pancreatic and colorectal cancers.
- Recent findings highlight synthetic lethality as a promising therapeutic strategy, identifying various epigenetic markers that could predict tumor response to ATR/CHK1 and ATM inhibitors, which may enhance treatment efficacy.
- Additionally, Zhang's studies address other health concerns, including the inflammatory mechanisms of Sjogren's syndrome and the role of palliative care screening tools in improving patient outcomes, showcasing a diverse research portfolio that bridges cancer biology and patient care.
